Two binding sites for ouabain in cardiac cell membranes

Area of Science:

• Cardiology
• Pharmacology
• Molecular Biology

Background:

• Cardiac glycosides, like ouabain, are used to treat heart failure.
• Their mechanism of action involves binding to specific receptors on cardiac cells.
• The relationship between ouabain binding and its effects on cardiac function requires further clarification.

Purpose of the Study:

• To define cardiac glycoside receptors by measuring 3H-ouabain binding and its functional effects.
• To investigate the correlation between ouabain binding affinity and its impact on cardiac cell membranes and contractility.
• To re-evaluate the hypothesis that (Na+ + K+)-ATPase inhibition is essential for ouabain-induced positive inotropy.

Main Methods:

• Simultaneous measurement of 3H-ouabain binding and its effects on cardiac cell membranes.
• Assessment of cardiac cell contractility in contracting cardiac muscle.
• Analysis of ouabain binding and (Na+ + K+)-ATPase activity in cultured cardiac cells.

Main Results:

• Rat and guinea pig cardiac cell membranes exhibit two distinct ouabain binding sites.
• Ouabain binding to the high-affinity site correlates with positive inotropic effects in cardiac muscle.
• Inhibition of (Na+ + K+)-ATPase activity is associated with binding to the low-affinity site.

Conclusions:

• The findings question the necessity of (Na+ + K+)-ATPase inhibition for ouabain's positive inotropic effect.
• Ouabain binding sites may exhibit heterogeneity, potentially influenced by potassium levels.
• This heterogeneity could be relevant in digitalis-sensitive species like cats and humans.